Ardent Health (NYSE:ARDT) Stock Price Down 3.5% – Time to Sell?

Ardent Health, Inc. (NYSE:ARDT) shares traded down 3.5% during mid-day trading on Friday . The stock traded as low as $8.78 and last traded at $8.73. 163,234 shares changed hands during trading, a decline of 62% from the average session volume of 427,915 shares. The stock had previously closed at $9.05.

Analyst Ratings Changes

ARDT has been the subject of a number of research analyst reports. Bank of America reduced their price target on shares of Ardent Health from $12.00 to $10.00 and set an “underperform” rating for the company in a research note on Thursday, November 13th. Leerink Partners set a $16.00 target price on shares of Ardent Health in a research report on Friday, November 14th. Truist Financial decreased their target price on shares of Ardent Health from $21.00 to $13.00 and set a “buy” rating for the company in a research note on Friday, November 14th. The Goldman Sachs Group began coverage on Ardent Health in a research note on Tuesday, October 14th. They issued a “neutral” rating and a $19.00 price target on the stock. Finally, Royal Bank Of Canada reduced their price objective on Ardent Health from $21.00 to $16.00 and set an “outperform” rating for the company in a research report on Friday, November 14th. Six research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $15.00.

Ardent Health Stock Down 3.0%

The company’s 50-day simple moving average is $13.03 and its two-hundred day simple moving average is $13.05. The firm has a market capitalization of $1.26 billion, a P/E ratio of 6.06, a P/E/G ratio of 7.45 and a beta of 0.44. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.08 and a quick ratio of 1.95.

Ardent Health (NYSE:ARDT) last posted its quarterly earnings data on Wednesday, November 12th. The company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.42 by $0.10. Ardent Health had a return on equity of 19.02% and a net margin of 3.24%.The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.55 billion. Ardent Health has set its FY 2025 guidance at 0.850-1.030 EPS. As a group, research analysts expect that Ardent Health, Inc. will post 1.23 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. CWM LLC raised its stake in Ardent Health by 990.6% during the 2nd quarter. CWM LLC now owns 2,203 shares of the company’s stock worth $30,000 after acquiring an additional 2,001 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in shares of Ardent Health in the third quarter worth $61,000. Quarry LP raised its position in shares of Ardent Health by 1,519.4% during the 1st quarter. Quarry LP now owns 5,020 shares of the company’s stock valued at $69,000 after purchasing an additional 4,710 shares during the period. KLP Kapitalforvaltning AS bought a new stake in shares of Ardent Health during the 3rd quarter valued at $80,000. Finally, New York State Common Retirement Fund lifted its stake in shares of Ardent Health by 121.4% during the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after buying an additional 3,400 shares in the last quarter.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.